- Combination Treatment With Bosentan and Sildenafil to Patients With Eisenmengers Syndrome
- Eisenmenger Syndrome in the Nordic Countries
- Phosphodiesterase-5 Inhibitor in Eisenmenger Syndrome
- Sleep-disordered Breathing in Eisenmenger Syndrome
- The Effects of Inhaled Iloprost on Congenital Heart Disease With Eisenmenger Syndrome
Clinical Trials
- Brief Behavioral Treatment for Anxiety in Young Children
- Evaluating an Online Adjunctive Support Following Intensive Services (OASIS) Strategy for Youth With Selective Mutism
- Evaluating Intensive Group Behavioral Treatment for Children With Selective Mutism
- Evaluating the Results of Physician and Parent Decisions to Treat Selective Mutism With Fluoxetine
- Factors Influencing Selective Mutism
- Improving Access to Child Anxiety Treatment
- Integrated Behavioral Therapy for Treating Children With Selective Mutism
- Randomised Controlled Treatment Study of Selective Mutism
- The Efficacy of Integrated Behavioral Therapy for Selective Mutism
- Treatment of Social Anxiety Disorder and Selective Mutism
- Web-Based CBT Protocol for Treatment of Selective Mutism
- What Treatment Works for Children With Selective Mutism?
- A 3-day Course for CFS/ME
- A Non-Interventional Pilot Study to Explore the Role of Gut Flora in ME/CFS
- A Trial of Solriamfetol in the Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
- Analysis of Post-exertional Malaise Using a Two-day CPET in People With ME/CFS
- Assessment of N-Acetylcysteine as Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
- Autoimmunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
- B-cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome
- B-cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Very Severe Chronic Fatigue Syndrome
- Cardiopulmonary Testing in ME/CFS to Improve Diagnostic Accuracy
- Cardiovascular Analysis of PEM
- Complex Chronic Diseases Program Data Registry
- Does a Technology Enabled Multi-disciplinary Team-based Care Model for the Management of Long COVID and Other Fatiguing Illnesses Improve Clinical Care of Patients and Represent a Sustainable Approach Within a Federally Qualified Health Center?
- Effect of CoQ10 Plus Selenium Supplementation on Clinical Outcomes and Biochemical Markers in ME/CFS (CoSeME Study)
- Effect of Probiotics in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
- Inspiratory Muscle Training in ME/CFS and COVID-19 Survivors
- Investigating the Role of Early Intravenous Immunoglobulin Treatment for Children With Encephalitis
- Long-term Sequelae of COVID-19 (Myalgic Encephalomyelitis): An International Cross-Sectional Study
- New MRT Imaging Biomarkers and Treatment With Kinetic Oscillatory Stimulation (KOS) in Nasal Cavity for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
- Oral Melatonin Plus Zinc Supplementation in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)
- Pilot Study of Alternative Treatments of Unexplained Chronic Fatigue
- RESTORE ME — RCT of Oxaloacetate on Improving Fatigue in ME/CFS
- Survey and Cognitive Behavior Therapy for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis
- The Comeback Study
- The Exercise Response to Pharmacologic Cholinergic Stimulation in Preload Failure
- The Norwegian Study of Chronic Fatigue Syndrome in Adolescents: Pathophysiology and Intervention Trial
- The Study of the Safety and Efficacy of Ampligen in Chronic Fatigue Syndrome
- Tumor Necrosis Factor-alpha Inhibition Using Etanercept in Chronic Fatigue Syndrome
- Accelerated Treatment of Endocarditis
- Artificial Valve Endocarditis Reduction Trial
- Clinical and Diagnostic Features of Endocarditis
- Combination Therapy With Fluoroquinolone in Staphylococcus Aureus Bacteremia
- Cytosorb Therapy in Cardiac Surgery
- Diagnosis of Septicaemia by Detection of Microbial DNA in Blood in Severe Infections
- Diagnostic Accuracy of 18FDG-PET-CT for Pacing or Defibrillation Lead Infection
- Evaluation of the Prognostic Impact of a Neuro-vascular Examination Associated With Cerebral MRI in the Acute Phase of Infectious Endocarditis
- Freestyle Prosthesis for Aortic Root-replacement With and Without Hemiarch Replacement
- Human Cardiac Mitochondria in Acute Endocarditis and Obesity
- Impact of Early Cardiac Surgery in Severe Left Endocarditis With Neurological Complications: a Retrospective Study
- Interest of Parametric Positron Emission Imaging in the Diagnosis of Infections on Cardiac Valve Prosthesis
- Management of Infectious Endocarditis as Part of a Multidisciplinary Consensus Meeting
- Pharmacokinetics/ Pharmacodynamics (PK/PD) Study of Vancomycin
- Postoperative Antibiotic Management Duration Following Surgery for Intravenous Drug Abuse (IVDA) Endocarditis (OPTIMAL)
- Retrospective Evaluation of Safety and Efficacy of Daptomycin Used in Patients With Serious Gram-positive Infections
- Virulence of Staphylococcus Lugdunensis in Severe Infections
- 2D Versus 3D Radical Laparoscopic Hysterectomy for Endometrial Cancer: a Prospective Randomized Trial
- 2D vs 3D Planning for High-Dose Rate (HDR) Gynecological Brachytherapy
- 3 Year Recurrence Free Survival in Ultra-low-risk Endometrial Cancer
- 4FMFES-PET Imaging of Endometrial and Ovarian Cancers
- A Controlled Study of Quality of Life and it’s Related Factors Among Gynecological Cancer Survivors
- A Novel Tapered Applicator for Vaginal Vault Brachytherapy
- A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors
- A Phase 1b/2 Study of Serabelisib in Combination With Canagliflozin in Patients With Advanced Solid Tumors
- A Phase 2 Feasibility Study of Abraxane and Carboplatin in Epithelial Neoplasms of the Uterus
- A Phase 2 Study of Mirvetuximab Soravtansine (IMGN853) and Pembrolizumab in Endometrial Cancer (EC)
- A Phase 2 Study of Oral MKC-1 in Patients With Ovarian or Endometrial Cancer
- A Phase II Study of Futibatinib and Pembrolizumab in Metastatic Microsatellite Stable Endometrial Carcinoma
- A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer
- A Phase II, Single-Arm Study of RAD001 (Everolimus), Letrozole, and Metformin in Patients With Advanced or Recurrent Endometrial Carcinoma
- A Pilot Study to Determine the Efficacy of Fluorescein Visualization of the Uterus in Detecting Endometrial Cancer Invasion
- A Pre-Op Window Study Evaluating Anti-Proliferative Effects of Atorvastatin on the Endometrium
- A Prospective Study Comparing Three Injection Sites to Detect Sentinel Lymph Nodes in Endometrial Cancer
- A Randomized, Controlled, Comparative Study of a Levonorgestrel Intrauterine System for the Prevention of Endometrial Cancer in Patients Aged 40-50 With BMI Greater Than 35
- A Safety and Efficacy of CCRT With Paclitaxel as Adjuvant Therapy to Post-Operative Advanced Endometrial Cancer Patients
- A Study Assessing the Safety and Utility of PINPOINT® Near Infrared Fluorescence Imaging in the Identification of Lymph Nodes in Patients With Uterine and Cervical Malignancies Who Are Undergoing Lymph Node Mapping
- A Study of Combination of Temsirolimus (Torisel®) and Pegylated Liposomal Doxorubicin (PLD, Doxil®/Caelyx®) in Advanced or Recurrent Breast, Endometrial and Ovarian Cancer
- A Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
- A Study of Ixabepilone as Second-line Therapy for Locally Advanced, Recurrent, or Metastatic Endometrial Cancer
- A Study of Ketogenic Diet in Newly Diagnosed Overweight or Obese Endometrial Cancer Patients
- A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer
- A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue Treatment
- A Study of Patients Receiving High-Dose Rate Brachytherapy
- A Study of Sacituzumab Govitecan in Metastatic Solid Tumors (TROPICS-03)
- A Study of Targeted Agents With Atezolizumab for Patients With Recurrent or Persistent Endometrial Cancer
- A Study of Various Treatments in Serous or p53 Abnormal Endometrial Cancer
- A Study to Assess the Efficacy and Safety of ABTL0812
- A Trial for Patients With Advanced/Recurrent Endometrial Cancer
- Abemaciclib With Letrozole in Recurrent or Persistent Endometrial Cancer
- Accuracy of Sentinel Lymph Node Biopsy in Nodal Staging of High Risk Endometrial Cancer
- Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health
- Adipocytokines in Endometrial Cancer
- Adipocytokines in Endometrial Cancer
- Adjuvant Hypofractionated Whole Pelvis Radiation Therapy in Endometrial Cancer
- Adjuvant Radiotherapy in Patients With Early Endometrial Cancer
- Adjuvant Sequential & Concurrent CarboTaxol + Radiotherapy for High Risk Endometrial Cancer
- Adjuvant Stereotactic Pelvic Irradiation in Endometrial Cancer
- Advanced Methods for Cancer Detection by Vaginal Screening
- Advanced or Recurrent Ovarian, Cervical, and Endometrial Cancer Treated With SHetA2
- Aminopterin in Treating Patients With Recurrent or Refractory Endometrial Cancer
- An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer
- An Enhanced Vaginal Dilator to Reduce Radiation-Induced Vaginal Stenosis
- Analysis of miRNA Expression in Endometrial Cancer
- Anti-ALPP CAR-T Cells Immunotherapy for Ovarian and Endometrial Cancer
- Anti-PD-1 Antibody Combined With Anlotinib in the Treatment of Endometrial Cancer
- Antitumoral Activity and Safety of AEZS-108 in Women With LHRH Receptor Positive Gynecological Tumors
- Anxiety and Distress Levels in Women With Suspected Endometrial Cancer
- AP23573 in Female Adult Patients With Recurrent or Persistent Endometrial Cancer (8669-019)(COMPLETED)
- Application of Tachosil During Lymphadenectomy
- Application of Thrombin Gel Matrix for the Prevention of Lymphocele in Patients With Endometrial Cancer.
- Arsenic Trioxide in Recurrent and Metastatic Ovarian Cancer and Endometrial Cancer With P53 Mutation
- Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
- Assessment of Screening Modalities for Gynecologic Cancers
- Bariatric Surgery for Fertility-Sparing Treatment of Atypical Hyperplasia and Grade 1 Cancer of the Endometrium
- Bevacizumab and Rucaparib in Recurrent Carcinoma of the Cervix or Endometrium
- BEZ235 Trial in Patients With Advanced Endometrial Carcinoma
- Biomarker Guided Treatment in Gynaecological Cancer
- Biomarkers for Diagnosis and Prognosis of Endometrial Carcinoma
- Biomarkers for Gynecologic Cancer
- Biomarkers in Tissue Samples From Patients With Stage I or Stage III Endometrial Cancer
- BKM120 in Advanced, Metastatic, or Recurrent Endometrial Cancers
- Bone Marrow Sparing Image-Guided Radiation Therapy (RT) Incorporating Novel Use of GCSF and FDG-PET Imaging
- Bone Mineral Density and Subsequent Cancer Risk
- BP1001-A in Patients With Advanced or Recurrent Solid Tumors
- Bristol-Myers Squibb Dasatinib Src Inhibition in Endometrial Cancer
- Can 3D Ultrasound be Used as an Alternative to MRI to Assess Myometrial Invasion in Endometrial Cancer?
- Can Staging Magnetic Resonance Imaging (MRI) Features Prognosticate Patients Presenting With Endometrial Cancer?
- Can the iKnife Distinguish Between Normal and Malignant Endometrial Tissue?
- Cancer of the Uterus and Treatment of Stress Urinary Incontinence
- Carboplatin-cyclophosphamide Combined With Atezolizumab
- Carboplatin, Docetaxel, and Radiation Therapy in Treating Patients With Stage III/IV, or Recurrent Endometrial Cancer
- Carboplatin, Paclitaxel With or Without Avelumab in Advanced or Recurrent Endometrial Cancer
- Carboplatin/Taxol/Ridaforolimus in Endometrial, Ovarian and Solids
- Cell-free DNA Methylation for Endometrial Cancer
- Cervical and Endometrial Injection for Sentinel Lymph Node Detection in Endometrial Cancer
- CerviPrep for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial, Cervical, or Ovarian Epithelial Cancer
- Chemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer
- Choosing Ovarian Preservation or Removal Before Surgery for Endometrial Cancer
- Clinical Characters of the Diagnosis and Treatment of Gynecological Malignant Tumors in China : A Real World Study
- Clinical Database and Biobank of Patients With Gynecologic Neoplasms
- Clinical Effects of Metformin on Fertility-sparing Treatment for Early Endometrial Cancer
- Clinical Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy
- Clinical Trial of Ridaforolimus Compared to Progestin or Chemotherapy for Advanced Endometrial Carcinoma (MK-8669-007 AM6)
- COM701 in Subjects With Advanced Solid Tumors
- Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer
- Combination Chemotherapy With Nintedanib / Placebo in Endometrial Cancer
- Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
- Compare the Performance of Targeted Biopsy Versus Aspiration Biopsy With a Pipette for the Diagnosis of Endometrial Cancer
- Comparison of Nodal Staging in Endometrial Cancer
- Comparison of the Effects of Fentanyl, Oxycodone, Butorphanol on Gastrointestinal Function
- Comparison of Toxicities Between Proton Therapy and IMRT for Post Operative Treatment of Endometrial or Cervical Cancers.
- Compliance to Vaginal Dilation Therapy in Patients Who Have Undergone Radiation Therapy For Stage IB, Stage IIA, Stage IIB, Stage IIIA, or Stage IIIB Cervical Cancer or Stage IA, Stage IB, Stage IIA, or Stage IIB Endometrial Cancer
- Concurrent Laparoscopic Hysterectomy and Weight Loss Surgery in Obese Patients With Endometrial Carcinoma or Endometrial Intraepithelial Neoplasia
- Concurrent Use Lymphoseek & Indocyanine Green in Sentinel Lymph Node Detection in Endometrial Cancer
- Continuation of Follow-up of DES-Exposed Cohorts
- Cost-utility of Ambulatory Surgery in the Management of Endometrial Cancer(AMBU-ENDO)
- CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers
- Crizotinib in c-MET Mutation Metastatic/Recurrent/Persistent Endometrial Cancer
- CT Assessment of BMI in Endometrial Cancer Patients
- Cytokine Regulation of Natural Killer Receptors in Inhibiting Activated T Cell Function
- Cytologic Analysis of Distention Media as a Screening Test for Endometrial Cancer
- Danazol in Treating Patients With Advanced or Recurrent Endometrial Cancer
- Dendritic Cells for Immunotherapy of Metastatic Endometrial Cancer Patients
- Detection of SLN in Patients With Endometrial Cancer Undergoing Robotic Assisted Staging: Comparison of ISB and ICG
- Determining the Sensitivity of Sentinel Lymph Nodes Identified With Robotic Fluorescence Imaging
- Diagnostic Accuracy of MRI, DWI MRI, FDG-PET/CT and FEC PET/CT in the Detection of Lymph Node Metastases in Surgically Staged Endometrial and Cervical Carcinoma
- Different Risk Stratification Models for Prediction of Lymph Node Involvement in Endometrial Carcinoma
- Disseminated Endometrial Cancer Cells During Sonohysterography
- Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)
- Dose Finding Study Of PF-05212384 With Paclitaxel And Carboplatin In Patients With Advanced Solid Tumor
- DOvEEgene: Diagnosing Ovarian and Endometrial Cancer Early Using Genomics
- Doxorubicin and Cisplatin With or Without Paclitaxel in Treating Patients With Locally Advanced, Metastatic, and/or Relapsed Endometrial Cancer
- Doxorubicin Hydrochloride Liposome and Carboplatin in Treating Patients With Recurrent, Stage III, or Stage IV Primary Endometrial Cancer
- Doxorubicin, Paclitaxel, and Carboplatin in Treating Patients With Primary Stage III, Stage IV, or Recurrent Endometrial Cancer
- Effect of a Lifestyle Intervention on Nutritional Status and Prognosis of Endometrial Cancer Survivors
- Effect of Fertility-sparing Therapy of Early Endometrial Cancer
- Effect of Uterine Manipulator on Recurrence and Mortality of Endometrial Cancer
- Effectiveness of Care in Certified Cancer Centres in Germany
- Effects of Centering Pre-operative Counseling on Patient Reported Anxiety
- Efficacy and Tolerability Study of Progesterone Vaginal Tablets (Endometrin®) in Menopausal Women Treated by Estrogen
- Efficacy of Paxman Scalp Cooling to Prevent Chemo Induced Alopecia in Black Patients With Breast or GYN Cancers
- Efficacy of PET/MRI in Detecting Metastatic Disease in Endometrial Cancer
- Efficacy Study of Chemotherapy Followed by Radiation Therapy to Treat Endometrial Cancer
- Efficacy Study of FloSeal for Prevention of Lymphocele After Lymphadenectomy for Gynecologic Cancer
- END-1: First Line Chemotherapy for Advanced or Recurrent Endometrial Carcinoma With Carboplatin and Liposomal Doxorubicin
- Endometrial Cancer – LOHP Alone and With 5FU
- Endometrial Cancer and Robotic-assisted Versus Traditional Laparoscopy
- Endometrial Cancer Biomarker Changes Following Exposure to Metformin
- Endometrial Cancer Conservative Treatment (E.C.Co). A Multicentre Archive
- Endometrial Cancer Diet and Exercise
- Endometrial Cancer International Database
- ENdometrial Cancer SURvivors’ Follow-up carE (ENSURE): Less is More?
- Endometrial Cancer Testing With Vaginal and Endometrial Cell Samples
- Endometrial Changes in Breast Cancer Women With or Without Hormonal Therapies
- Endometrial Polyps: Pathophysiology and Clinical Consequences
- Epidemiological Analysis on Endometrial Cancer in Guangdong Province of China
- Erlotinib in Treating Patients With Locally Advanced and/or Metastatic Endometrial Cancer
- Estrogen Replacement Therapy in Treating Women With Early-Stage Endometrial Cancer
- Estrogen, Diet, Genetics and Endometrial Cancer
- European Collaborative Multicenter Observational Study: Modular Treatment With PMMR and Targeted Compartmental Pelvic Lymphadenectomy Followed by Therapeutic Pelvic and Paraaortic Lymphadenectomy in Node Positive Disease for Locoregional Control in Endometrial Cancer FIGO Stages I-III
- Evaluating the Effect of Perioperative Caloric Restriction Program on Perioperative Outcomes in Patients With Obesity and Endometrial Cancer
- Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer
- Evaluation of Carboplatin/Paclitaxel/Bevacizumab in the Treatment of Advanced Stage Endometrial Carcinoma
- Evaluation of Fluciclovine Uptake in Patients With Cervical, Ovarian Epithelial or Endometrial Cancers.
- Evaluation of Indocyanine Green-guided Systematic Pelvic Lymphadenectomy in Endometrial and Cervical Cancer
- Evaluation of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-α Positive Endometrial Cancer
- Evaluation of the Molecular Effects of Metformin on the Endometrium in Patients With Endometrial Cancer
- Evaluation of the Proliferative Activities of Insulin Analogues in Primary Human Tumor Cells
- Evaluation of Thiol Disulfide Balance in Stage 1 Endometrium Cancer
- Everolimus in Treating Patients With Relapsed or Metastatic Endometrial Cancer
- Exemestane in Advanced and Recurrent Endometrial Carcinoma
- Exercise and Healthy Diet or Standard Care in Patients in Remission From Stage I or Stage II Endometrial Cancer
- Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemotherapy
- Exercise as an Intervention in Endometrial Cancer Survivors
- Exploring HIFU as a Treatment for Rectal and Other Pelvic Cancers
- Exploring the Potential of Novel Biomarkers Based on Plasma microRNAs for a Better Management of Pelvic Gynecologic Tumors
- Expression of Altered Glycosyltransferases, Mucins, and RTKs in Human Ovarian and Endometrial Cancers
- Extended Follow-up of Columbia, MO Serum Bank Participants
- External-Beam Radiation Therapy Compared With Vaginal Brachytherapy After Surgery for Stage I Endometrial Cancer
- Factors Affecting the Prognosis of Patients With Endometrial Cancer
- Feasibility of a Clinical Trial Comparing the Use of Cetirizine to Replace Diphenhydramine in the Prevention of Reactions Related to Paclitaxel
- Feasibility Study of Laparoendoscopic Single Site Surgical Staging for Endometrial Cancer
- Feasibility Study Using the Xoft System for the Treatment of Endometrial Cancer
- Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer
- Fertility Sparing Management of EndomeTrial Cancer and Hyperplasia
- Fertility-sparing Management Using High-dose Oral Progestin in Young Women With Endometrial Cancer
- FESPET Study: Female EStrogen recePtor in Endometrial Cancer Treatment
- Flavopiridol in Treating Patients With Recurrent or Persistent Endometrial Cancer
- Follow-up of Endometrial Cancer Patients
- Follow-up of Gynecological Cancer Patients, Their Needs and Expectations, A Cooperation Project
- FPA150 in Patients With Advanced Solid Tumors
- Frontline Immunotherapy Combined With Radiation and Chemotherapy in High Risk Endometrial Cancer
- Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial Cancer
- Genistein in Preventing Breast or Endometrial Cancer in Healthy Postmenopausal Women
- GINECO-EN102b – BKM120 as Monotherapy in the Treatment of Initial or Recurrent Metastatic Endometrial Cancer
- Gyn Onc Prehab Study
- HE4 is a Beneficial Biomarker in Endometrial Cancer
- High Intensity Interval Training in Endometrial Cancer
- Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Recurrent, Advanced, or Metastatic Endometrial Cancer
- Hula, a Physical Activity Intervention for Female-Cancer Survivors
- Human Epididymis Protein 4 in Endometrial Carcinoma
- Hysteroscopic Lymphatic Mapping for Endometrial Cancer
- Hysteroscopic vs. Cervical Injection for Sentinel Node Detection of Endometrial Cancer
- Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study
- Implementing Enhanced Recovery After Surgery (ERAS) Pathways In Major Gynecologic Oncology Operations In Greece
- Improving Care After Inherited Cancer Testing
- Indocyanine Green and Near-infrared Fluorescence Imaging to Detect Sentinel Lymph Nodes in Patients With Endometrial Cancer
- Intensity Modulated Radiotherapy (IMRT) for the Pelvis Post-Hysterectomy
- Intra-Operative Lymphatic Mapping in Patients With Invasive Carcinoma of the Cervix or Endometrial Carcinoma
- Intraoperative Examination of Sentinel Node in Endometrial Cancer (TRSGO-SLN-003)
- Intraoperative Pathological Evaluation for Surgical Treatment & Staging for Endometrial Cancer
- Intravenous Weekly Topotecan In Subjects With Recurrent Or Persistent Endometrial Cancer
- Investigating the Use of Fluorescence Imaging in Endometrial Cancer Surgery
- Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial Cancer
- Ketohexokinase Isoforms in Endometrial Cancer.
- Laparoscopic Approach to Cancer of the Endometrium
- Laparoscopic Hysterectomy and Weight Loss Surgery in Obese Patients With Endometrial Carcinoma/Intraepithelial Neoplasia
- Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer
- Letrozole in the Treatment of Advanced or Recurrent Hormone Receptor Positive Endometrial Cancer
- Letrozole in Treating Women With Recurrent or Metastatic Endometrial Cancer
- Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer and Cervical Cancer
- Lifestyle Change and Quality of Life in Obese Patients With Stage I/II Endometrial Cancer in Remission
- Linking Obesity and Estrogen-responsive Genes in Endometrial Cancer
- Liposomal Doxorubicin in Treating Patients With Advanced or Recurrent Endometrial Cancer
- Lymph Node Mapping in Patients With Endometrial Cancer
- Lymphedema in Endometrial Cancer
- Lymphoseek as Lymphoid Tissue Targeting Agent in Patients With Cancer of the Endometrium
- Macrobiotic Diet and Flax Seed: Effects on Estrogens, Phytoestrogens, & Fibrinolytic Factors
- Maintenance With Selinexor/Placebo After Combination Chemotherapy in Endometrial Cancer [SIENDO]
- Metformin With the Levonorgestrel-Releasing Intrauterine Device for the Treatment of Complex Atypical Hyperplasia (CAH) and Endometrial Cancer (EC) in Non-surgical Patients
- Mindfulness in Endometrial and Cervical Cancer
- Mirena® ± Metformin as Fertility-preserving Treatment for Young Asian Women With Early Endometrial Cancer
- Mirvetuximab Soravtansine (IMGN853) and Bevacizumab in Patients With Endometrial Cancer
- MK-3475 Immunotherapy in Endometrial Carcinoma
- Modality of Adjuvant Radiotherapy and Chemotherapy for Stage Ⅲ Endometrial Cancer
- Molecular Staging of Endometrial Cancer
- MOtiVating Endometrial Cancer Survivors With Activity Monitors and Tailored Feedback
- Motivational Interviewing to Increase Physical Activity Behaviour in Cancer Patients
- Multi-omics Study on the Pathogenesis of Malignant Transformation of Adenomyosis
- Multimedia Aid Gynecologic Counseling and Consent
- Multiorgan Metabolic Imaging Response Assessment of Abemaciclib
- Neoadjuvant Celecoxib in Newly Diagnosed Patients With Endometrial Carcinoma
- Non-Hormonal Vaginal Moisturizer in Hormone-Receptor Positive Postmenopausal Cancer Survivors Experiencing Estrogen Deprivation Symptoms on Vulvovaginal Health
- Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease
- Onapristone and Anastrozole in Refractory Estrogen and Progesterone Positive Endometrial Cancer
- ONC201 in Recurrent or Metastatic Type II Endometrial Cancer Endometrial Cancer
- ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma
- Open-label Phase 1b Study of ARQ 092 in Combination With Anastrozole
- Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies – (FIGHT-101)
- OSCAR ENDO One Stop Assessment of Risk for Endometrial Hyperplasia and Cancer
- Oxaliplatin in Treating Patients With Persistent or Recurrent Endometrial Cancer
- Paclitaxel in Treating Patients With Refractory or Recurrent Endometrial Cancer
- Papillary Serous Carcinoma of the Endometrium
- Patient-Reported Outcomes Among Women Wtih Gynecological Cancer (The CONNECT Study)
- Patient’s Experience and Choice Between Investigations for Endometrial Cancer in Postmenopausal Bleeding
- Pelvic IMRT With Tomotherapy in Post-Hysterectomy Endometrial Cancer Patients
- Pelvic Sentinel Node Detection Using Indocyanine Green Learning Curve
- Pembro/Carbo/Taxol in Endometrial Cancer
- Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors
- Pembrolizumab in Ultramutated and Hypermutated Endometrial Cancer
- Pembrolizumab With Ataluren in Patients With Metastatic pMMR and dMMR Colorectal Carcinoma or Metastatic dMMR Endometrial Carcinoma: the ATAPEMBRO Study
- Pembrolizumab With Axitinib in Recurrent Endometrial Cancer
- Pemetrexed Disodium in Treating Patients With Persistent or Recurrent Endometrial Cancer
- PET-CT vs. Integrated MR-PET Scanning of GYN Cancers
- PET/CT in the Management of Patients With Early Stage Endometrial Cancer
- Pharmacology Study of Aerosolized Liposomal 9-Nitro-20 (S)-Camptothecin (L9NC)
- Phase 1/2a Evaluation of AL3818 in Subjects With Recurrent or Metastatic Endometrial, Ovarian or Cervical Cancer (AL3818-US-001)
- Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
- Phase I BKM120/Abraxane in Solid Tumors, Expansion Phase Recurrent Endometrial or Ovarian Cancer
- Phase I/IIa Trial of Folate Binding Protein Vaccine in Ovarian Cancer
- Phase II Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC)
- Phase II Study of Atezolizumab + Bevacizumab in Endometrial Cancer
- Phase III Study Comparing 3D Conformal Radiotherapy and Conformal Radiotherapy IMRT to Treat Endometrial Cancer
- Phenotypic Spectrum of CTCs in Tumors of the Female Reproductive System
- Photoacoustic Endoscopy in Endometrial Cancer
- Physical Activity After Endometrial Cancer
- Pilot Study Using a PET Gamma Probe to Evaluate Lymph Nodes in Endometrial Cancer
- Pilot Study: Can Ultrasound Guided Biopsy be Used as an Alternative to Hysteroscopy?
- Pilot Trial of SP-2577 Plus Pembrolizumab in Select Gynecologic Cancers
- PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Colorectal, or Gastric Cancer
- PORTEC-4a: Molecular Profile-based Versus Standard Adjuvant Radiotherapy in Endometrial Cancer
- Positron Emission Tomography (PET) Imaging Studies With NIS Reporter
- Positron Lymphography Via Intracervical 18F-FDG Injection for Pre-surgical Lymphatic Mapping in Stage IB1 Cervical Cancer and High-grade Endometrial Cancer
- Pre-operative Studies for Prediction of Lymph Nodes Involvement in Endometrial Cancer Patients
- Predictive Clinical and Biological Parameters in Gynecological Cancer – GC-BIO-IPC 2013-010
- Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients
- Preliminary Study of Endometrial Hyperplasia Groundwork for a Study to Define Precursors of Endometrial Cancer
- Preoperative Window Study of Metformin for the Treatment of Endometrial Cancer
- Prevalence of Self Reported Lymphedema in Patients With Endometrial Cancer
- Probe-based and Needle-based Confocal Laser Endomicroscopy During Gynaecological Procedures.
- PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors
- Prognostic Impact of Programmed Death Ligand-1 Expression in Advanced Endometrial Cancer
- Programmed Death-1(PD-1) Inhibitor Combined With Progesterone Treatment in Endometrial Cancer
- Prospective Randomised Phase II Trial Evaluating Adjuvant Pelvic Radiotherapy Using Either IMRT or 3-Dimensional Planning for Endometrial Cancer. ICORG 09-06
- Prospective Randomized Comparison of Sentinel Lymph Node Mapping and Conventional Pelvic Lymph Node Dissection in Early Stage Endometrial Cancer
- Prospective, Observational Study of Low-risk Criteria for Node Metastasis in Endometrial Cancer
- Protein-Sparing Modified Fast Intervention for Weight Loss in Obese Endometrial Cancer Survivors
- Psychosocial Benefits of Exercise in Endometrial Cancer Survivors
- Quality of Life After Robotic Surgery for Endometrial Cancer
- Quality of Life in Survivors of Gynecologic Cancer
- Racial Disparity in Endometrial Cancer
- RAD001 in Recurrent Endometrial Cancer Patients
- Radiation and TSR-042 in People With Endometrial Cancer After They Receive Surgery
- Radiation Therapy in Uterine Cancer: Dosimetry Analysis, Clinical Implication, and Survival Analysis
- Raloxifene in Treating Patients With Persistent or Recurrent Endometrial Cancer
- Relationship of Endometrial Cancer and Serum Soluble L1CAM Level
- Reliability and Interest of Circulating Tumor DNA in Endometrial Cancers.
- Research of Circulating Tumor Cells Released During Endometrial Cancer Surgery.
- Retrospective Case Study Examining Patient Outcomes Compared to the ChemoFx Assay in Endometrial Cancer Patients
- Retrospective Study to Evaluate the Feasibility of Ovarian Preservation in Patients With Endometrial Carcinoma
- Risk Assessment of Endometrial Hyperplasia and Endometrial Cancer
- Risk Factors for Endometrial Cancer in Black Women
- Robot Assisted Laparoscopic Hysterectomy vs. Abdominal Hysterectomy in Endometrial Cancer
- Robot-assisted Laparoscopic Hysterectomy-RALH- Postoperative Complications, Quality of Life and Health Economics
- ROGYcare: The Impact of a Cancer Survivorship Care Plan on Patient Reported Outcomes and Health Care Providers
- Role of Uterine Manipulator in Hysterectomy – Ro.Man.HY
- Rucaparib and Nivolumab in Patients With Prostate or Endometrial Cancer
- Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Women With Suspected Ovarian or Endometrial Cancer
- Safety and Efficacy of Metronomic Cyclophosphamide, Metformin and Olaparib in Endometrial Cancer Patients
- Safety and Efficacy of Retifanlimab (INCMGA00012) Alone or in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-based Chemotherapy.
- Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers
- Safety and Tolerability of DS-7423 in Subjects With Advanced Solid Malignant Tumors
- Safety of BKM120 Monotherapy in Advanced Solid Tumor Patients
- Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules
- Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies
- Scale Down for Endometrial Cancer
- Screening for Endometrial Abnormalities in Overweight and Obese Women
- Screening of Biomarkers on Endometrial Cancers
- Selective Inhibitor of Nuclear Export, Selinexor (KPT-330) in Combination With Paclitaxel and Carboplatin in Patients With Advanced Ovarian or Endometrial Cancers
- Selective Surgical Staging for the Treatment of Endometrial Cancer Based on Intraoperative Consultation
- Selective Targeting of Adjuvant Therapy for Endometrial Cancer (STATEC)
- Sentinel Lymph Node Biopsy Predictive Value in Endometrial Cancer of Low and Intermediate Risk
- Sentinel Lymph Node Biopsy Versus Lymphadenectomy in Endometrial Cancer
- Sentinel Lymph Node Dissection (SLND) in Patients With Apparent Early Stage Endometrial Cancer
- Sentinel Node Biopsy in Endometrial Cancer
- Sentinel Node Detection in Endometrial Cancer: A Consolidation Study on Detection Rates of Metastatic Disease
- Sentinel Node in Endometrial Cancer
- Sentinel Node Mapping in High Risk Endometrial Cancer
- Sexual Functioning in Endometrial Cancer
- Single Agent ONC201 in Recurrent or Metastatic Endometrial Cancer
- SLNM in Endometrial Cancer Combined With OSNA
- Social Interventions for Support During Treatment for Endometrial Cancer and Recurrence
- Stereotactic Pelvic Adjuvant Radiation TherApy in Cancers of the UteruS
- Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus II
- Stratifying Endometrial Cancer Patients Using a PET/MRI Prognostic Model
- Study of BN83495 in Post-menopausal Women With Endometrial Cancer Post-chemotherapy
- Study of Copanlisib and Ketogenic Diet
- Study of CYH33, an Oral α-specific PI3K Inhibitor in Combination With Olaparib an Oral PARP Inhibitor in Patients With Advanced Solid Tumors.
- Study of Genes and the Environment in Patients With Endometrial Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom
- Study of Insulin Resistance and Endometrial Cancer in Harris County, Texas
- Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
- Study of LY3023414 for the Treatment of Recurrent or Persistent Endometrial Cancer
- Study of Niraparib and TSR-042 in Recurrent Endometrial Cancer
- Study of Pembrolizumab, Radiation and Immune Modulatory Cocktail in Cervical/Uterine Cancer
- Study of PF‑06940434 in Patients With Advanced or Metastatic Solid Tumors.
- Study of Post Operative Pain in Endometrial Cancer Robotic Versus Laparotomy
- Study of the Weekly Oral RAD001 in Combination With Oral Topotecan in Patients With Advanced or Recurrent Endometrial Cancers
- Study of Vaginal Dilator Use After Pelvic Radiotherapy
- Study of Vintafolide (MK-8109, EC145) in Participants With Advanced Ovarian and Endometrial Cancers (MK-8109-007, EC-FV-02)
- Study to Evaluate PM01183 in Combination With Olaparib in Advanced Solid Tumors
- Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers
- Surgery Plus Medroxyprogesterone in Preventing Endometrial Cancer
- Survivorship Promotion In Reducing IGF-1 Trial
- SYD985 in Patients With HER2-expressing Recurrent, Advanced or Metastatic Endometrial Carcinoma
- Systematic Pelvic Lymphadenectomy Versus no Lymphadenectomy in Clinical Stage I-II Endometrial Cancer
- Tachosil for the Prevention of Symptomatic Lymph Cysts
- Tailored Adjuvant Therapy in POLE-mutated and p53-wildtype Early Stage Endometrial Cancer
- Targeted Disruption to Cancer Metabolism and Growth Through Dietary Macronutrient Modification
- Telephone Follow-up After Treatment for Endometrial Cancer
- The Compatibility of Preoperative Endometrial Biopsies With Postoperative Final Pathology in Endometrial Cancer
- The DETECT Study: Discovery and Evaluation of Testing for Endometrial Cancer in Tampons
- the Effectiveness of a Weight Management Program in Patients Who Have Completed Treatment for Endometrial Cancer
- The Effects of the Endocrine System on Endometrial Cancer
- The LYSA (Linking You to Support and Advice) Trial
- The Multicentic Trial in Fertility-sparing Treatment and Ovarian Preservation Management for Early Endometrial Cancer
- The Role of Endometrial Blood Flow in Endometrial Cancer
- The Role of Functional MRI and Doppler Sonography in Assessing Blood Vessel Formation Within the Tumors of Endometrial Cancer Patients
- The Role of Micrometastasis and Isolated Tumor Cells (ITCs) in Endometrial and Cervical Cancer. A Multicenter Study.
- The Study of Oral Steroid Sulphatase Inhibitor BN83495 Versus Megestrol Acetate (MA) in Women With Advanced or Recurrent Endometrial Cancer
- The UPPROACH (Upfront Intensity Modulated Proton Beam Therapy) Approach
- Thunderbeat Technology vs Standard Bipolar Electro-surgery in Total Laparoscopic Hysterectomy With Pelvic Lymphadenectomy for Endometrial Cancer
- Time Restricted Eating (TRE) Among Endometrial Cancer Patients
- Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors
- Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors
- Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors.
- To Assess and Compare the Performance Two Approach for Sentinel Lymph Node (SNLD) Biopsy for Endometrial Cancer
- Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies
- Tracers for Endometrial Cancer Sentinel Node Labeling
- Translating Healthy Lifestyle Interventions for Cancer Survivors
- Transvaginal Natural Orifice Endoscopic Surgery for Extremely Obese Patients With Early-stage Endometrial Cancer
- Treatment With Medroxyprogesterone Acetate Plus LNG-IUS in Young Women With Early Stage Endometrial Cancer
- TREC Lifestyle Beyond Cancer Study in Endometrial Cancer Survivors
- Trial Between Two Follow up Regimens With Different Test Intensity in Endometrial Cancer Treated Patients
- Trial of Letrozole + Palbociclib/Placebo in Metastatic Endometrial Cancer
- Trial of Maintenance With Niraparib- Uterine Serous Carcinoma
- TSR-042 in Addition to Standard of Care Definitive Radiation for Inoperable Endometrial Cancer
- Tumor Grade Determines PD-1/PDL-1 Expression
- Upper Vaginectomy Versus Brachytherapy in Patients With Early Stage Endometrial Cancer Treated With Laparoscopic Surgery
- Urinary miRNA in Endometrial Cancer Study
- Use of an Intrauterine Manipulator and Its Correlation With Positive Peritoneal Cytology in Early Stage Endometrial Cancers
- Usefulness of 18F-FDG PET/CT in the Initial Staging and Surveillance of Endometrial Cancer Patients
- Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer
- Vaginal Cuff Brachytherapy Followed by Chemotherapy in Endometrial Cancer
- Vaginal Cuff Brachytherapy Followed by Chemotherapy in Patients With Endometrioid Cancer
- Vaginal Cuff Brachytherapy Fractionation Study
- Value of Diffusion Weighted Magnetic Resonance Imaging in Detection of Recurrent Disease in Surgically Treated Cervical and Endometrial Cancer Patients
- Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC
- Vibrational Spectroscopy for Endometrial Cancer Diagnosis
- VIrtual REality Glasses for the Enhancement of Acute BRACHYtherapy Tolerance for Endometrial Cancer Patients.
- Window of Opportunity Study of Pembrolizumab in Early Stage, High Grade Obesity-driven Endometrial Cancer
- Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
- Evaluation of Clinical Impact of Interruption VS Maintenance of AI in Patients With Locally Advanced/ Metastatic Low Grade Endometrial Stromal Sarcoma (LGESS)
- Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492
- Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer
- 24-Week Induction Study of APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE-3)
- A Food Additive Removal Diet for Pediatric Eosinophilic Esophagitis
- A Phase 2 Study of Barzolvolimab in Patients With Eosinophilic Esophagitis
- A Prospective Study of the Four Food Elimination Diet for Treatment of Eosinophilic Esophagitis
- A Randomized Double Blind Placebo Controlled Study of the Effect of Swallowed Beclomethasone Dipropionate on Inflammatory Markers in Adult Patients With Eosinophilic Esophagitis
- A Registry for Patients With Food Allergy
- A Six Month, Safety Follow-up Study in Eosinophilic Esophagitis Subjects Who Completed Study PR-021
- A Study Comparing Swallowed Flovent and Placebo in Patients With Eosinophilic Disorders
- A Study Evaluating Potential Disease-Mediated Drug-Drug Interaction in Adult Participants With Active Eosinophilic Esophagitis Receiving Cendakimab
- A Study in Adolescents and Adults With Eosinophilic Esophagitis (EoE) Measuring Histologic Response and Determine if Reduction in Dysphagia is Achieved
- A Study of Antolimab (AK002) in Patients With Active Eosinophilic Esophagitis
- A Study of Baked Milk Tolerance to Treat Eosinophilic Esophagtis
- A Study of Benralizumab in Patients With Eosinophilic Esophagitis
- A Study of Detergents in the Pathogenesis of Eosinophilic Esophagitis
- A Study of Flovent in Patients With Eosinophilic Esophagitis
- A Study to Assess the Efficacy, Safety and Tolerability of IRL201104 in Adults With Active Eosinophilic Esophagitis
- A Study to Assess the Safety and Efficacy of Oral Etrasimod in Adult Participants With Eosinophilic Esophagitis
- A Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis
- A Study to Investigate Safety and Tolerability of NDX-3315 in Healthy Participants and Patients With Eosinophilic Esophagitis
- A Study to Investigate the Efficacy and Tolerability of ESO-101 in Patients With Eosinophilic Esophagitis
- A Trial Evaluating EP-104IAR in Adults With Eosinophilic Esophagitis
- A Trial of Montelukast for Maintenance Therapy of Eosinophilic Esophagitis in Children
- a4b7 Integrin in Eosinophilic Esophagitis
- An Extension Study to Evaluate Maintenance of Efficacy and Long-term Treatment Effect of Oral Budesonide Suspension (OBS) in Adults and Adolescents With Eosinophilic Esophagitis (EoE)
- An Intervention Study to Improve Therapeutic Compliance in Adult Patients With Eosinophilic Esophagitis.
- An Open-Label Trial of Losartan Potassium in Participants With Eosinophilic Esophagitis (EoE)
- Antihistamines in Eosinophilic Esophagitis
- Application of a Novel Allergen-Specific Immune Signature Directed Approach to Dietary Elimination Therapy in Patients With Eosinophilic Esophagitis (IDiET)
- Assessing Risk of Food Insecurity Within Households of Children With Food Allergy
- Bethanechol for Eosinophilic Esophagitis
- Budesonide Effervescent Tablets vs. Viscous Budesonide Suspension vs. Placebo in Eosinophilic Esophagitis
- Budesonide for Eosinophilic Esophagitis
- Budesonide Orodispersible Tablet vs. Placebo in Active Eosinophilic Esophagitis
- Budesonide Versus Fluticasone for Treatment of Eosinophilic Esophagitis
- CEGIR 7807: Validation of Online Cohort of EGID Patients Enrolled in RDCRN CEGIR Contact Registry
- CEGIR 7808: Use of Unsedated Transnasal Esophagoscopy (TNE) to Monitor Dietary Management of Eosinophilic Esophagitis in Children
- Changes in Esophageal Distensibility With Proton Pump Inhibitors in Patients With Esophageal Eosinophilia: A Pilot Study
- Characteristics and Inflammatory Markers in Children With Eosinophilic Esophagitis (EoE)
- Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
- Comparing Anesthetic Techniques in Children Having Esophagogastroduodenoscopies
- Comparison of Esophageal Clearance Times of Oral Budesonide Preparations
- Comparison of Histology From a Mesh Sponge and Traditional Esophageal Biopsies in Children and Adolescents With EoE
- Confocal Laser Endomicroscopy in Patients With Eosinophilic Esophagitis
- Cow’s Milk Elimination for Treatment of Eosinophilic Esophagitis
- Cycling of Topical Steroids for Treatment of EoE (Eosinopilic Esophagitis)
- Cytosponge and Dietary Therapy in EoE
- Cytosponge Protocol IRB 11-006429
- Data Bank for Eosinophilic Disorders
- Diagnosis and Monitoring of Eosinophilic Esophagitis Using the Cytosponge
- Dose Escalation Study to Evaluate an Experimental New Treatment (CALY-002) in Healthy Subjects and Subjects With Celiac Disease and Eosinophilic Esophagitis
- Dose Ranging Study of RPC4046 in Eosinophilic Esophagitis
- Eating With Eosinophilic Esophagitis (EoE)
- Effects of Swallowed Steroids on Bone Density and Growth in Pediatric Eosinophilic Esophagitis
- Efficacy and Safety APT-1011 in Adolescent Subjects With Eosinophilic Esophagitis (EoE) – A Sub-Study of the FLUTE-2 Trial
- Efficacy and Safety APT-1011 in Subjects With Eosinophilic Esophagitis (EoE) (FLUTE-2)
- Efficacy and Safety of QAX576 in Patients With Eosinophilic Esophagitis
- Efficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis
- Efficacy and Safety of Three Doses of Florence Oral Suspension in Adults With Eosinophilic Esophagitis
- Efficacy and Safety Study of Reslizumab to Treat Eosinophilic Esophagitis in Subjects Aged 5 to 18 Years
- Efficacy of Dupilumab on Facilitated Food Introduction in Eosinophilic Esophagitis
- Efficacy of Low-Dose Topical Steroids in Maintaining Remission of Eosinophilic Esophagitis in Children
- Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
- EndoFLIP Use in Upper GI Tract Stenosis
- Endoscopic Characterisation of Inflammation in EoE
- EoE Food Desensitization
- EoE RCT Fluticasone and Omeprazole vs Fluticasone Alone
- EoE(Eosinophilic Esophagitis)
- Eosinophil β1 Integrin Activation as a Biomarker for Eosinophilic Esophagitis
- Eosinophilic Esophagitis Databank
- Eosinophilic Esophagitis Intervention Trial-1 Food vs. 4 Food Elimination Diet Followed by Swallowed Glucocorticoids
- Eosinophilic Esophagitis Treatment: Montelukast vs Fluticasone
- Eosinophilic Esophagitis: Influence of Dilation on Dysphagia and Inflammation
- Eosinophilic Gastrointestinal Disorders Patient Registry
- Eosinophilic Gastrointestinal Disorders Registry
- Esophageal Absorption in EoE
- Esophageal Motility in Eosinophilic Esophagitis Evaluated by High Resolution Manometry.
- Esophageal String Test in Eosinophilic Esophagitis
- Evaluation of Efficacy, Safety and Patient’ Satisfaction of Therapeutic Switch From Off-Steroids to Budesonide
- Exhaled Nitric Oxide as a Biomarker of Disease Activity in Eosinophilic Esophagitis
- Expanded Access Protocol for Patients With Eosinophilic Esophagitis
- Fibrostenotic Eosinophilic Esophagitis: Assessment Tools
- Food Antigen in Eosinophilic Esophagitis
- Imaging of the Esophagus Using a SECM Capsule
- Immunopathogenesis of Food Allergy and Eosinophilic Gastrointestinal Disorders
- Improved Diagnostics of Celiac Disease in Children
- Inflammatory Mediators as Potential Non-Invasive Biomarkers in Subjects With Eosinophilic Esophagitis
- Innate Immunity in Eosinophilic Esophagitis
- Maintenance of Remission With Budesonide Orodispersible Tablets vs. Placebo in Eosinophilic Esophagitis
- Mepo for EoE Study
- Mesalazine Oral Suspension in Active Eosinophilic Esophagitis
- Metabolomic Profiling of Eosinophilic Esophagitis
- Metabolomics for Biomarker Discovery in Children With EoE
- Milk Patch for Eosinophilic Esophagitis
- Molecular Basis of Food Allergy
- Mometasone-furoate for Treatment of Eosinophilic Esophagitis – a Randomized Placebo Controlled Study.
- MRI to Assess Fibrosis in Eosinophilic Esophagitis Patients
- Mucosal Impedance and Eosinophilic Esophagitis
- Mucosal Impedance Balloon in Diagnosis and Treatment of Eosinophilic Esophagitis (EoE)
- Mucosal Impedance in Pediatric Population
- Nasal Nitric Oxide Levels in Eosinophilic Esophagitis (EoE)
- National, Multicenter, Retrospective, Prospective Study to Evaluate Pediatric Gastrointestinal Eosinophilic Disorders
- Natural History of Eosinophilic Esophagitis
- New Serological Markers for Eosinophilic Esophagitis
- Non-endoscopic Tracking of Disease Activity in Eosinophilic Esophagitis
- OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages
- Open-Label Extension Study of Reslizumab in Pediatric Subjects With Eosinophilic Esophagitis
- Oral Cromolyn Sodium for the Treatment of Eosinophilic Esophagitis
- Pharmacokinetics, Efficacy, Tolerability and Safety of Different Budesonide Oral Gel Doses in Adults’ Subjects of Both Genders With Eosinophilic Esophagitis (EoE)
- Phenotypic Characterization and Biomarkers Investigation for Eosinophilic Esophagitis in Pediatric Patients
- Pilot Study of Esocheck in Eosinophilic Esophagitis
- Prevalence of Eosinophilic Esophagitis in Children With Celiac Disease
- Prevalence of Food Allergies in a Cohort of Adult Patients With Eosinophilic Esophagitis
- Proof of Concept Study of OC000459 in Eosinophilic Esophagitis
- Prospective Database for Eosinophilic Esophagitis (EoE) of Pediatric Population
- Prospective Multicenter Nationwide Registry of Children With Eosinophilic Esophagitis
- Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis Assessed by Transnasal Endoscopy (TNE)
- Radiation Dose in Humans From Orally Administered Tc99m-Heparin
- Registry for Eosinophilic Gastrointestinal Disorders (REGID)
- Risk Factors and Biomarkers for Diagnosis and Treatment of EoE
- SAD, MAD and Food Effect Evaluation of Safety, Tolerability, and PK of AQ280 in Healthy Subjects
- Safety and Pharmacokinetics of Orodispersible BT-11 in Active Eosinophilic Esophagitis
- Safety and Tolerability Study of Oral EUR-1100 to Treat Eosinophilic Esophagitis
- Safety Study of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis
- Short Duration 6Fed Sponge For EoE Patients
- Sirolimus for Eosinophil-Associated Gastrointestinal Disorders
- SOFEED: Six Food vs. One Food Eosinophilic Esophagitis Diet Study
- Somatization, Anxiety, and Disordered Sleep in Pediatric Eosinophilic Esophagitis
- Sponge and Eosinophil Peroxidase (EPO) Staining
- Study of the Efficiency of Esophageal Dilation on Patient With Eosinophilic Esophagitis
- Study to Image the Esophagus Using the OFDI Capsule
- Study to Investigate the Efficacy and Safety of Dupilumab in Pediatric Patients With Active Eosinophilic Esophagitis (EoE)
- Survey About the Relationship Beetween Allergic Rhinitis and Seasonal EOE Exacerbations
- Swallowing Characteristics of Pediatric Patients With Eosinophilic Esophagitis
- Targeted Elimination Diet in EoE Patients Following Identification of Trigger Nutrients Using Confocal Laser Endomicroscopy
- Testing Effectiveness of Losartan in Patients With EoE With or Without a CTD
- The Effect of Sucralfate Slurry in Patients With Eosinophilic Esophagitis
- The Efficacy and Tolerability of 12-weeks Treatment With Almond and Buckwheat Based Formula in Pediatric Patients With Active EoE
- The Immune Directed Individualized Elimination Therapy (iDIET) Study
- The Role Of Gastroesophageal Reflux Disease (GERD) in Eosinophilic Esophagitis
- The Role of HRM and Specific Biomarkers of Inflammation in the Diagnosis of Patients With Dysphagia and Suspected EoE
- The Use of Fractionated Exhaled Nitric Oxide in the Diagnosis and Assessment of Disease Activity of Eosinophilic Esophagitis
- The Use of Fractionated Exhaled Nitric Oxide in the Diagnosis and Assessment of Disease Activity of Eosinophilic Esophagitis (Validation Phase)
- Tolerability of Goat Milk Protein in Eosinophilic Esophagitis Patients With Cow Milk Protein Trigger
- Topical Budesonide Treatment for Eosinophilic Esophagitis (EoE)
- Topical Steroid Treatment for Eosinophilic Esophagitis
- Trial of Montelukast in Eosinophilic Esophagitis
- Use of Esophageal String Test to Understand Symptoms, Inflammation, and Function in Eosinophilic Esophagitis
- Using Spectrally Encoded Confocal Microscopy (SECM) to Image the Esophagus
- Value of Patch Testing in Direct Diet Therapy for Eosinophilic Esophagitis
- Zemaira Eosinophilic Esophagitis Pilot Study
- 24-Week Induction Study of APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE-3)
- A Food Additive Removal Diet for Pediatric Eosinophilic Esophagitis
- A Phase 2 Study of Barzolvolimab in Patients With Eosinophilic Esophagitis
- A Prospective Study of the Four Food Elimination Diet for Treatment of Eosinophilic Esophagitis
- A Randomized Double Blind Placebo Controlled Study of the Effect of Swallowed Beclomethasone Dipropionate on Inflammatory Markers in Adult Patients With Eosinophilic Esophagitis
- A Registry for Patients With Food Allergy
- A Six Month, Safety Follow-up Study in Eosinophilic Esophagitis Subjects Who Completed Study PR-021
- A Study Comparing Swallowed Flovent and Placebo in Patients With Eosinophilic Disorders
- A Study Evaluating Potential Disease-Mediated Drug-Drug Interaction in Adult Participants With Active Eosinophilic Esophagitis Receiving Cendakimab
- A Study in Adolescents and Adults With Eosinophilic Esophagitis (EoE) Measuring Histologic Response and Determine if Reduction in Dysphagia is Achieved
- A Study of Antolimab (AK002) in Patients With Active Eosinophilic Esophagitis
- A Study of Baked Milk Tolerance to Treat Eosinophilic Esophagtis
- A Study of Benralizumab in Patients With Eosinophilic Esophagitis
- A Study of Detergents in the Pathogenesis of Eosinophilic Esophagitis
- A Study of Flovent in Patients With Eosinophilic Esophagitis
- A Study to Assess the Efficacy, Safety and Tolerability of IRL201104 in Adults With Active Eosinophilic Esophagitis
- A Study to Assess the Safety and Efficacy of Oral Etrasimod in Adult Participants With Eosinophilic Esophagitis
- A Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis
- A Study to Investigate Safety and Tolerability of NDX-3315 in Healthy Participants and Patients With Eosinophilic Esophagitis
- A Study to Investigate the Efficacy and Tolerability of ESO-101 in Patients With Eosinophilic Esophagitis
- A Trial Evaluating EP-104IAR in Adults With Eosinophilic Esophagitis
- A Trial of Montelukast for Maintenance Therapy of Eosinophilic Esophagitis in Children
- a4b7 Integrin in Eosinophilic Esophagitis
- An Extension Study to Evaluate Maintenance of Efficacy and Long-term Treatment Effect of Oral Budesonide Suspension (OBS) in Adults and Adolescents With Eosinophilic Esophagitis (EoE)
- An Intervention Study to Improve Therapeutic Compliance in Adult Patients With Eosinophilic Esophagitis.
- An Open-Label Trial of Losartan Potassium in Participants With Eosinophilic Esophagitis (EoE)
- Antihistamines in Eosinophilic Esophagitis
- Application of a Novel Allergen-Specific Immune Signature Directed Approach to Dietary Elimination Therapy in Patients With Eosinophilic Esophagitis (IDiET)
- Assessing Risk of Food Insecurity Within Households of Children With Food Allergy
- Bethanechol for Eosinophilic Esophagitis
- Budesonide Effervescent Tablets vs. Viscous Budesonide Suspension vs. Placebo in Eosinophilic Esophagitis
- Budesonide for Eosinophilic Esophagitis
- Budesonide Orodispersible Tablet vs. Placebo in Active Eosinophilic Esophagitis
- Budesonide Versus Fluticasone for Treatment of Eosinophilic Esophagitis
- CEGIR 7807: Validation of Online Cohort of EGID Patients Enrolled in RDCRN CEGIR Contact Registry
- CEGIR 7808: Use of Unsedated Transnasal Esophagoscopy (TNE) to Monitor Dietary Management of Eosinophilic Esophagitis in Children
- Changes in Esophageal Distensibility With Proton Pump Inhibitors in Patients With Esophageal Eosinophilia: A Pilot Study
- Characteristics and Inflammatory Markers in Children With Eosinophilic Esophagitis (EoE)
- Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
- Comparing Anesthetic Techniques in Children Having Esophagogastroduodenoscopies
- Comparison of Esophageal Clearance Times of Oral Budesonide Preparations
- Comparison of Histology From a Mesh Sponge and Traditional Esophageal Biopsies in Children and Adolescents With EoE
- Confocal Laser Endomicroscopy in Patients With Eosinophilic Esophagitis
- Cow’s Milk Elimination for Treatment of Eosinophilic Esophagitis
- Cycling of Topical Steroids for Treatment of EoE (Eosinopilic Esophagitis)
- Cytosponge and Dietary Therapy in EoE
- Cytosponge Protocol IRB 11-006429
- Data Bank for Eosinophilic Disorders
- Diagnosis and Monitoring of Eosinophilic Esophagitis Using the Cytosponge
- Dose Escalation Study to Evaluate an Experimental New Treatment (CALY-002) in Healthy Subjects and Subjects With Celiac Disease and Eosinophilic Esophagitis
- Dose Ranging Study of RPC4046 in Eosinophilic Esophagitis
- Eating With Eosinophilic Esophagitis (EoE)
- Effects of Swallowed Steroids on Bone Density and Growth in Pediatric Eosinophilic Esophagitis
- Efficacy and Safety APT-1011 in Adolescent Subjects With Eosinophilic Esophagitis (EoE) – A Sub-Study of the FLUTE-2 Trial
- Efficacy and Safety APT-1011 in Subjects With Eosinophilic Esophagitis (EoE) (FLUTE-2)
- Efficacy and Safety of QAX576 in Patients With Eosinophilic Esophagitis
- Efficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis
- Efficacy and Safety of Three Doses of Florence Oral Suspension in Adults With Eosinophilic Esophagitis
- Efficacy and Safety Study of Reslizumab to Treat Eosinophilic Esophagitis in Subjects Aged 5 to 18 Years
- Efficacy of Dupilumab on Facilitated Food Introduction in Eosinophilic Esophagitis
- Efficacy of Low-Dose Topical Steroids in Maintaining Remission of Eosinophilic Esophagitis in Children
- Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
- EndoFLIP Use in Upper GI Tract Stenosis
- Endoscopic Characterisation of Inflammation in EoE
- EoE Food Desensitization
- EoE RCT Fluticasone and Omeprazole vs Fluticasone Alone
- EoE(Eosinophilic Esophagitis)
- Eosinophil β1 Integrin Activation as a Biomarker for Eosinophilic Esophagitis
- Eosinophilic Esophagitis Databank
- Eosinophilic Esophagitis Intervention Trial-1 Food vs. 4 Food Elimination Diet Followed by Swallowed Glucocorticoids
- Eosinophilic Esophagitis Treatment: Montelukast vs Fluticasone
- Eosinophilic Esophagitis: Influence of Dilation on Dysphagia and Inflammation
- Eosinophilic Gastrointestinal Disorders Patient Registry
- Eosinophilic Gastrointestinal Disorders Registry
- Esophageal Absorption in EoE
- Esophageal Motility in Eosinophilic Esophagitis Evaluated by High Resolution Manometry.
- Esophageal String Test in Eosinophilic Esophagitis
- Evaluation of Efficacy, Safety and Patient’ Satisfaction of Therapeutic Switch From Off-Steroids to Budesonide
- Exhaled Nitric Oxide as a Biomarker of Disease Activity in Eosinophilic Esophagitis
- Expanded Access Protocol for Patients With Eosinophilic Esophagitis
- Fibrostenotic Eosinophilic Esophagitis: Assessment Tools
- Food Antigen in Eosinophilic Esophagitis
- Imaging of the Esophagus Using a SECM Capsule
- Immunopathogenesis of Food Allergy and Eosinophilic Gastrointestinal Disorders
- Improved Diagnostics of Celiac Disease in Children
- Inflammatory Mediators as Potential Non-Invasive Biomarkers in Subjects With Eosinophilic Esophagitis
- Innate Immunity in Eosinophilic Esophagitis
- Maintenance of Remission With Budesonide Orodispersible Tablets vs. Placebo in Eosinophilic Esophagitis
- Mepo for EoE Study
- Mesalazine Oral Suspension in Active Eosinophilic Esophagitis
- Metabolomic Profiling of Eosinophilic Esophagitis
- Metabolomics for Biomarker Discovery in Children With EoE
- Milk Patch for Eosinophilic Esophagitis
- Molecular Basis of Food Allergy
- Mometasone-furoate for Treatment of Eosinophilic Esophagitis – a Randomized Placebo Controlled Study.
- MRI to Assess Fibrosis in Eosinophilic Esophagitis Patients
- Mucosal Impedance and Eosinophilic Esophagitis
- Mucosal Impedance Balloon in Diagnosis and Treatment of Eosinophilic Esophagitis (EoE)
- Mucosal Impedance in Pediatric Population
- Nasal Nitric Oxide Levels in Eosinophilic Esophagitis (EoE)
- National, Multicenter, Retrospective, Prospective Study to Evaluate Pediatric Gastrointestinal Eosinophilic Disorders
- Natural History of Eosinophilic Esophagitis
- New Serological Markers for Eosinophilic Esophagitis
- Non-endoscopic Tracking of Disease Activity in Eosinophilic Esophagitis
- OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages
- Open-Label Extension Study of Reslizumab in Pediatric Subjects With Eosinophilic Esophagitis
- Oral Cromolyn Sodium for the Treatment of Eosinophilic Esophagitis
- Pharmacokinetics, Efficacy, Tolerability and Safety of Different Budesonide Oral Gel Doses in Adults’ Subjects of Both Genders With Eosinophilic Esophagitis (EoE)
- Phenotypic Characterization and Biomarkers Investigation for Eosinophilic Esophagitis in Pediatric Patients
- Pilot Study of Esocheck in Eosinophilic Esophagitis
- Prevalence of Eosinophilic Esophagitis in Children With Celiac Disease
- Prevalence of Food Allergies in a Cohort of Adult Patients With Eosinophilic Esophagitis
- Proof of Concept Study of OC000459 in Eosinophilic Esophagitis
- Prospective Database for Eosinophilic Esophagitis (EoE) of Pediatric Population
- Prospective Multicenter Nationwide Registry of Children With Eosinophilic Esophagitis
- Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis Assessed by Transnasal Endoscopy (TNE)
- Radiation Dose in Humans From Orally Administered Tc99m-Heparin
- Registry for Eosinophilic Gastrointestinal Disorders (REGID)
- Risk Factors and Biomarkers for Diagnosis and Treatment of EoE
- SAD, MAD and Food Effect Evaluation of Safety, Tolerability, and PK of AQ280 in Healthy Subjects
- Safety and Pharmacokinetics of Orodispersible BT-11 in Active Eosinophilic Esophagitis
- Safety and Tolerability Study of Oral EUR-1100 to Treat Eosinophilic Esophagitis
- Safety Study of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis
- Short Duration 6Fed Sponge For EoE Patients
- Sirolimus for Eosinophil-Associated Gastrointestinal Disorders
- SOFEED: Six Food vs. One Food Eosinophilic Esophagitis Diet Study
- Somatization, Anxiety, and Disordered Sleep in Pediatric Eosinophilic Esophagitis
- Sponge and Eosinophil Peroxidase (EPO) Staining
- Study of the Efficiency of Esophageal Dilation on Patient With Eosinophilic Esophagitis
- Study to Image the Esophagus Using the OFDI Capsule
- Study to Investigate the Efficacy and Safety of Dupilumab in Pediatric Patients With Active Eosinophilic Esophagitis (EoE)
- Survey About the Relationship Beetween Allergic Rhinitis and Seasonal EOE Exacerbations
- Swallowing Characteristics of Pediatric Patients With Eosinophilic Esophagitis
- Targeted Elimination Diet in EoE Patients Following Identification of Trigger Nutrients Using Confocal Laser Endomicroscopy
- Testing Effectiveness of Losartan in Patients With EoE With or Without a CTD
- The Effect of Sucralfate Slurry in Patients With Eosinophilic Esophagitis
- The Efficacy and Tolerability of 12-weeks Treatment With Almond and Buckwheat Based Formula in Pediatric Patients With Active EoE
- The Immune Directed Individualized Elimination Therapy (iDIET) Study
- The Role Of Gastroesophageal Reflux Disease (GERD) in Eosinophilic Esophagitis
- The Role of HRM and Specific Biomarkers of Inflammation in the Diagnosis of Patients With Dysphagia and Suspected EoE
- The Use of Fractionated Exhaled Nitric Oxide in the Diagnosis and Assessment of Disease Activity of Eosinophilic Esophagitis
- The Use of Fractionated Exhaled Nitric Oxide in the Diagnosis and Assessment of Disease Activity of Eosinophilic Esophagitis (Validation Phase)
- Tolerability of Goat Milk Protein in Eosinophilic Esophagitis Patients With Cow Milk Protein Trigger
- Topical Budesonide Treatment for Eosinophilic Esophagitis (EoE)
- Topical Steroid Treatment for Eosinophilic Esophagitis
- Trial of Montelukast in Eosinophilic Esophagitis
- Use of Esophageal String Test to Understand Symptoms, Inflammation, and Function in Eosinophilic Esophagitis
- Using Spectrally Encoded Confocal Microscopy (SECM) to Image the Esophagus
- Value of Patch Testing in Direct Diet Therapy for Eosinophilic Esophagitis
- Zemaira Eosinophilic Esophagitis Pilot Study
- A Phase I Study of AdV-tk + Prodrug Therapy in Combination With Radiation Therapy for Pediatric Brain Tumors
- A Pilot Study Evaluating 18F-L-Thymidine (FLT) PET Imaging in Children With Gliomas
- A Trial of Surgery and Fractionated Re-Irradiation for Recurrent Ependymoma
- An International Clinical Program for the Diagnosis and Treatment of Children With Ependymoma
- Antineoplaston Therapy in Treating Patients With Ependymoma
- Carboplatin as a Radiosensitizer in Treating Childhood Ependymoma
- Everolimus for Children With Recurrent or Progressive Ependymoma
- Feasibility Trial of Optune for Children With Recurrent or Progressive Supratentorial High-Grade Glioma and Ependymoma
- HER2-specific CAR T Cells for Children With Ependymoma
- HUMC 1612: Optune NovoTTF-200A System
- Immunotherapy for Recurrent Ependymomas in Children Treatment for Recurrent Ependymomas Using HLA-A2 Restricted Tumor Antigen Peptides in Combination With Imiquimod
- Infusion of 5-Azacytidine (5-AZA) Into the Fourth Ventricle in Patients With Recurrent Posterior Fossa Ependymoma
- LET Optimized IMPT in Treating Pediatric Patients With Ependymoma
- Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma
- Marizomib for Recurrent Low-Grade and Anaplastic Supratentorial, Infratentorial, and Spinal Cord Ependymoma
- ONC206 for Treatment of Newly Diagnosed or Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant Brain Tumors (PNOC 023)
- Phase I Study of 5-Fluorouracil in Children and Young Adults With Recurrent Ependymoma
- SCRT Versus Conventional RT in Children and Young Adults With Low Grade and Benign Brain Tumors
- Single-agent Erlotinib in Patients Previously Treated With Oral Etoposide in Protocol OSI-774-205
- Study of the Effect of GM-CSF on Macrophages in Ependymoma
- Treatment of Children With Recurrent Refractory Brain/Solid Tumors and Recurrent Ependymoma
- Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine